US equities |
META $626.03 ▼-0.72% NVDA $217.82 ▲+0.84% MU $916.55 ▲+1.42% TSLA $397.04 ▲+1.38% GOOGL $318.32 ▲+0.48% INTC $92.06 ▲+1.76% AMD $540.04 ▲+1.65% BE $214.61 ▲+5.24%
FinancialContent

Actinium Pharmaceuticals, Inc. (Delaware) Common Stock (NY:ATNM)

1.401 +0.001 (+0.04%)
Delayed Quote Updated: 9:30 AM EDT, Oct 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Actinium Pharmaceuticals, Inc. (Delaware) Common Stock

< Previous 1 2 3 4 5 Next >
Actinium Pharmaceuticals Rally Takes Stock 62% Higher As Its Iomab-B Data Continues To Impress (NYSE AMERICAN: ATNM)
Via AB Newswire
Actinium Pharmaceuticals Rally Intact As Its Iomab-B Data Shows 100% Effectiveness In Targeted Patient Population (NYSE AMERICAN: ATNM)
Via AB Newswire
Actinium Pharmaceuticals Stock Jumps 17% Ahead Of SIERRA Trial Update; Iomab-B Shows 100% Effectiveness In Targeted Patient Population (NYSE AMERICAN: ATNM)
Via AB Newswire
News headline image
48 Biggest Movers From Friday ↗
Gainers Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) shares jumped 135.4% to settle at $5.32 on Friday. The stock possibly traded higher following favorable data results by... 
Via Benzinga
News headline image
53 Biggest Movers From Yesterday ↗
Gainers DICE Therapeutics, Inc. (NASDAQ: DICE) shares surged 117% to settle at $36.89 on Wednesday as the company priced its IPO at $17 per share. PROCEPT BioRobotics Corporation... 
Via Benzinga
Topics Initial Public Offering
News headline image
Why Actinium Pharmaceuticals' Stock Is Trading Higher Today ↗
Actinium Pharmaceuticals (AMEX:ATNM) shares are trading higher after the company announced it completed enrollment in the pivotal Phase 3 SIERRA trial of iomab-B.... 
Via Benzinga
News headline image
38 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Indaptus Therapeutics, Inc. (NASDAQ: INDP) shares jumped 177.2% to $19.60 after the company announced the United States Patent and Trademark Office has issued a notice of... 
Via Benzinga
Topics Intellectual Property
News headline image
Mid-Day Market Update: monday.com Jumps Following Strong Q2 Results; Kubient Shares Plunge ↗
Midway through trading Tuesday, the Dow traded down 0.81% to 35,336.88 while the NASDAQ fell 0.89% to 14,661.86. The S&P also fell, dropping 0.65% to 4,450.54. The U.S. has... 
Via Benzinga
Topics Stocks
News headline image
Actinium's Targeted Radiotherapy Achieves 100% Bone Marrow Transplant Engraftment ↗
Actinium Pharmaceuticals Inc (NYSE: ATNM) highlighted data from its pivotal Phase 3 SIERRA trial evaluating Iomab-B in patients with relapsed or refractory Acute... 
Via Benzinga
News headline image
Actinium Pharmaceuticals Details SIERRA at Benzinga Global Small Cap Business Conference ↗
Actinium Pharmaceuticals Inc. (NYSE: ATNM), a clinical-stage biopharmaceutical company that develops antibody radiation-conjugates (ARC), took part in the Benzinga Global Small... 
Via Benzinga
News headline image
Actinium Activates Radiation Inside the Body for Target Conditioning of Cancer Cells ↗
Actinium Pharmaceuticals Inc. (NYSE: ATNM), a clinical-stage biopharmaceutical company, is developing antibody radiation-conjugates (ARCs) to combine the targeting ability of... 
Via Benzinga
News headline image
Small-Cap Biotech Execs On Latest Advancements, Post-Pandemic Return To Fundamentals ↗
At the Benzinga Global Small Cap Conference Thursday, Jason McCarthy, senior managing director at Maxim Group, hosted a panel discussion on how biotech companies are getting back... 
Via Benzinga
< Previous 1 2 3 4 5 Next >